SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 41729.
  • 2
    Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66: 1216.
  • 3
    Rodríguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol 2007; 42: 556070.
  • 4
    Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 84557.
  • 5
    Rosenstiel P, Fantini M, Brautigam K et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003; 124: 10019.
  • 6
    Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 30: 515.
  • 7
    Curran ME, Lau KF, Hampe J et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998; 115: 106671.
  • 8
    Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-Le-Grand) 2003; 49: 277300.
  • 9
    Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8 alpha alpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008; 105: 208349.
  • 10
    Stio M, Martinesi M, Bruni S et al. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients. Int Immunopharmacol 2006; 6: 108392.
  • 11
    Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 14356.
  • 12
    Kiehne K, Brunke G, Wegner F, Banasiewicz T, Folsch UR, Herzig KH. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006; 12: 105662.
  • 13
    Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 113642.
  • 14
    Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihy droxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 264852.
  • 15
    Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 238692.
  • 16
    Kong J, Zhang Z, Musch MW et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G20816.
  • 17
    Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 2847.
  • 18
    Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 185055.
  • 19
    Wood RJ, Fleet JC. The genetics of osteoporosis: vitamin D receptor polymorphisms. Annu Rev Nutr 1998; 18: 23358.
  • 20
    Ingles SA, Ross RK, Yu MC et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 16670.
  • 21
    Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593617.
  • 22
    Naderi N, Farnood A, Habibi M et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23: 181622.
  • 23
    Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The Bsm I vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet Test 2004; 8: 41720.
  • 24
    Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 21114.
  • 25
    The cooperation group IBD of Chinese Medical Association Digestive Branch. Chinese consensus on diagnosis and treatment standard of inflammatory bowel disease. Chin J Dig 2007; 12: 48895 (in Chinese).
  • 26
    Schwartz BS, Lee BK, Lee GS et al. Association of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect 2000; 108: 94954.
  • 27
    Tokita A, Matsumoto H, Morrison NA et al. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 1996; 11: 10039.
  • 28
    Lim SK, Park YS, Park JM et al. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab 1995; 80: 367781.
  • 29
    Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 666569.
  • 30
    Hustmyer FG, Deluca HF, Peacock M. ApaI, BsmI, EcoRV and TaqI polymorphism at the human vitamin D receptor gene locus in Caucasians, Blacks and Asians. Hum Mol Genet 1993; 2: 487.
  • 31
    Leng S, Song W, Wang Y et al. Analysis of vitamin D receptor gene polymorphisms in 538 Chinese Han nationality. Chin J Prev Med 2002; 36: 314 (in Chinese).
  • 32
    Zhang H, Tao G, Gao Y et al. Studies on the distribution of vitamin D receptor gene polymorphism in Han, Uygur, Kazak and Mongoloid nationality in. China Chin J Osteoporos 2006; 12: 13 (in Chinese).
  • 33
    Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66: 121.
  • 34
    Naderi N, Farnood A, Habibi M et al. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2008; 23: 181622.
  • 35
    Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 112.
  • 36
    Ingles SA, Haile RW, Henderson BE et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997; 6: 938.
  • 37
    Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22: 20317.
  • 38
    Whitfield GK, Remus LS, Jurutka PW et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001; 177: 14559.
  • 39
    Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 2847.
  • 40
    Carling T, Rastad J, Akerstrom G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998; 83: 22559.
  • 41
    DeLuca HF. Vitamin D. Nutr Today 1993; 28: 611.
  • 42
    Clemens TL, Adams JS, Nolan JM, Holick MF. Measurement of circulating vitamin D in man. Clin Chim Acta 1982; 121: 3018.
  • 43
    Fleming CR. Nutrition in patients with Crohn's disease: another piece of the puzzle. JPEN J Parenter Enteral Nutr 1995; 19: 934.
  • 44
    Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998; 67: 91926.
  • 45
    Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32: 124755.
  • 46
    Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 238692.
  • 47
    Akutsu N, Lin R, Bastien Y et al. Regulation of gene expression by 1alpha, 25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 2001; 15: 112739.
  • 48
    Jiang F, Li P, Fornace AJ Jr, Nicosia SV, Bai W. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem 2003; 278: 4803040.
  • 49
    Khanim FL, Gommersall LM, Wood VH et al. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 2004; 23: 671225.
  • 50
    Palmer HG, Gonzalez-Sancho JM, Espada J et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154: 36987.
  • 51
    Sinotte M, Rousseau F, Ayotte P et al. Vitamin D receptor polymorphisms (Fok I Bsm I) and breast cancer risk: association replication in two case–control studies within French Canadian population. Endocr Relat Cancer 2008; 15: 97583.
  • 52
    Randerson Moor JA, Taylor JC, Elliott F et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45: 327181.